Ongoing Psychedelic Clinical Trials

With an up-to-date overview of ongoing global clinical trials, Floris Wolswijk, Founder at Blossom, will share insights from the company’s comprehensive psychedelic research database. Authoring the forthcoming Psychedelics as Medicine Report: Third Edition, Blossom is the insight engine of PSYCH, with unparalleled data and a team of global analysts.